Interaction Details

There were no interactions found between Durvalumab and Collagen Peptides. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Durvalumab and Collagen Peptides? Ask Dr. Brian Staiger about it by contacting him directly.

Collagen Peptides Overview

Collagen Peptides Collagen peptides are a form of collagen, a protein that is found in the connective tissue of animals. Collagen is a major component of the skin, tendons, ligaments, and bones, and it plays a key role in maintaining the strength and integrity of these tissues. Collagen peptides are made by breaking down collagen into smaller pieces, or peptides, which can be more easily absorbed by the body. It is sold as a dietary supplement and often marketed as being able to improve skin health, reduce inflammation, and enhance joint function. There is some evidence to suggest that collagen peptides may have certain health benefits when taken as a supplement. For example, studies have shown that collagen peptides can improve skin elasticity and reduce the appearance of wrinkles, as well as reduce joint pain and improve mobility in people with osteoarthritis. However, more research is needed to fully understand the potential benefits and risks of taking collagen peptides as a supplement. As a dietary protein, it is thought to be relatively safe to combine with most drugs.
See More Information Regarding Collagen Peptides

Durvalumab Overview

  • Durvalumab is used alone to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. It is also used in combination with tremelimumab-actl (Imjudo) and platinum-based chemotherapy to treat a certain type of NSCLC that has spread throughout the lungs and to other parts of the body. Durvalumab injection is also used in combination with chemotherapy agents to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body. It is also used in combination with chemotherapy agents to treat biliary tract cancer (BTC; cancer in the organs and ducts that make and store bile, the liquid made by the liver) in adults whose cancer has spread to nearby tissues or to other parts of the body. Durvalumab is also used in combination with tremelimumab-actl to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Durvalumab injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.

See More Information Regarding Durvalumab Injection

Collagen Peptides - More Interactions

Collagen Peptides interacts with 0 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main herbal interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist